XOMAP Stock Price, Chart, Stats & News
XOMA Royalty Corporation (XOMAP) is a dividend-paying stock with a current dividend yield of 8.63% as of Jul 13, 2026. It pays $2.16 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 11.38% 5-year compound annual rate.
Dividend safety
XOMAP pays out about 118% of earnings, leaving little safety margin.
XOMAP chart
Fundamentals
Gross margin | 94.32% |
Operating margin | 21.83% |
Pretax margin | 61.01% |
Net margin | 60.81% |
Effective tax rate | 0.02% |
ROA | 11.63% |
ROE | 32.61% |
D/E | 1.27x |
Interest coverage ratio | 0.87x |
XOMAP valuation
P/E | 13.72x |
P/S | 5.96x |
P/B | 4.48x |
P/CF | 166.95x |
P/FCF | 111.45x |
P/OCF | 166.95x |
PEG | -0.56x |
EV multiple | 18.28x |
About
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets.
Related lists
Similar securities
Based on sector and market capitalization
